Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
STK-002 by Stoke Therapeutics for Unspecified Ophthalmological Disorders: Likelihood of Approval
STK-002 is under clinical development by Stoke Therapeutics and currently in Phase I for Unspecified Ophthalmological Disorders. According to GlobalData,...